Latest Articles Page 100 of 338
-
Perspective June 30, 2023
P.1-2
Hematol Blood Disord: 6(2): 1-2
Cancer microenvironment and immune deficiency involved in chronic lymphocytic leukaemia
Author(s): Dino Fibber
-
Opinion Article June 26, 2023
P.1-2
Hematol Blood Disord: 6(2): 1-2
Adverse events associated with transfusion of RBCâ??s
Author(s): Mihaela Crisan
-
Commentary June 21, 2023
P.1-2
Hematol Blood Disord: 6(2): 1-2
Acute lymphoblastic leukemia and hematopoietic stem cell transplantation
Author(s): Colin Miles
-
Mini Review June 20, 2023
P.1-2
Hematol Blood Disord: 6(2): 1-2
Hemoglobin deficiency leads to develop aplhathalassemia
Author(s): Jafar Ali
-
Commentary June 30, 2023
P.1-2
J NeuroInform Neuroimaging: 8(3): 1-2
The role of lineage-specific transcriptional regulators in neurological cancers
Author(s): Aldaz Garros
-
Opinion Article June 19, 2023
P.1-2
Hematol Blood Disord: 6(2): 1-2
Donor availability and improving safety & efficacy of stem cell transplantation
Author(s): Curran Daily
-
Mini Review June 26, 2023
P.1-2
J NeuroInform Neuroimaging: 8(3): 1-2
COVID-19 and muscular involvement in neuromuscular diseases
Author(s): Scouiller Knak
-
Opinion Article June 21, 2023
P.1-2
J NeuroInform Neuroimaging: 8(3): 1-2
Genetic and molecular pathogenesis of glioblastoma multiforme
Author(s): Brem Rourke
-
Rapid Communication June 20, 2023
P.1-2
J NeuroInform Neuroimaging: 8(3): 1-2
Epigenetic alterations of brain tumor therapy
Author(s): Eyler Fontebasso
-
Case Report June 19, 2023
P.1-2
J NeuroInform Neuroimaging: 8(3): 1-2
Health technology assessment of gene therapies for neuromuscular diseases
Author(s): Lim Moore